These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6296219

  • 1. Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.
    Valente WA, Yavin Z, Yavin E, Grollman EF, Schneider M, Rotella CM, Zonefrati R, Toccafondi RS, Kohn LD.
    J Endocrinol Invest; 1982; 5(5):293-301. PubMed ID: 6296219
    [Abstract] [Full Text] [Related]

  • 2. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA, Valente WA, Ekins RP, Kohn LD, Marshall NJ.
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [Abstract] [Full Text] [Related]

  • 3. Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease.
    Lacetti P, Tombaccini D, Aloj S, Grollman EF, Kohn LD.
    Adv Exp Med Biol; 1984 Jan; 174():355-67. PubMed ID: 6331133
    [Abstract] [Full Text] [Related]

  • 4. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease.
    Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollman EF, Toccafondi RS, Kohn LD.
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6680-4. PubMed ID: 6292912
    [Abstract] [Full Text] [Related]

  • 6. Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease.
    Kohn LD, Valente WA, Laccetti P, Cohen JL, Aloj SM, Grollman EF.
    Life Sci; 1982 Nov; 32(1-2):15-30. PubMed ID: 6298540
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease.
    Yavin E, Yavin Z, Schneider MD, Kohn LD.
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3180-4. PubMed ID: 6265939
    [Abstract] [Full Text] [Related]

  • 8. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP, Amr S, Carayon P, Nisula BC.
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [Abstract] [Full Text] [Related]

  • 9. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P, Harrison LC.
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL, Erlanger BF.
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH, Gerend PL, Goretzki P, Nissenson RA.
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [Abstract] [Full Text] [Related]

  • 12. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y.
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [Abstract] [Full Text] [Related]

  • 13. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, Roberts E, Wilmot J, Richards T, Kiddie A, Small K, Platt H, Summerhayes S, Harris R, Reeve M, Coco G, Zanchetta R, Chen S, Furmaniak J, Smith BR.
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [Abstract] [Full Text] [Related]

  • 16. Unusual antagonistic actions of mixtures of vasoactive intestinal peptide, thyroid-stimulating antibodies, and cholera toxin on adenosine 3',5'-monophosphate accumulation in normal human thyroid cell cultures.
    Brandi ML, Rotella CM, Kohn LD, Toccafondi R.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1199-205. PubMed ID: 2871039
    [Abstract] [Full Text] [Related]

  • 17. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides.
    Desai RK, Dallas JS, Gupta MK, Seetharamaiah GS, Fan JL, Tahara K, Kohn LD, Prabhakar BS.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):658-63. PubMed ID: 8103771
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.